4504 ORAL A phase II study of continuous daily administration of sunitinib in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC) – final results
2007 ◽
Vol 5
(4)
◽
pp. 299-300
◽
Keyword(s):
Phase Ii
◽
Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma
2006 ◽
Vol 24
(6)
◽
pp. 487-491
◽
Keyword(s):
Phase Ii
◽